Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07AWM
|
|||
| Former ID |
DIB006924
|
|||
| Drug Name |
Segard
|
|||
| Synonyms |
Afelimomab
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Sepsis [ICD-11: 1G40-1G41; ICD-9: 995.91] | Discontinued in Phase 3 | [1] | |
| Company |
Abbott Laboratories
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002771) | |||
| REF 2 | Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med. 2001 Apr;29(4):765-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.